Global healthcare company Organon, gathered a panel of healthcare experts for its launch, to discuss the barriers and opportunities in advancing Lebanese women’s health and address the challenges they face through solutions tailored to their needs
Beirut, December 2021: In line with their mission to create a better and healthier every day for Lebanese women, especially during the unprecedented times that Lebanon has been witnessing, Organon, the only global company of its size focused mainly on women’s health, held a panel discussion around: Accelerating Advancements in the Health of Women and their Families. The event was attended by a group of experts and specialists from different medical fields, representatives of the Ministry of Public Health, and media figures including journalist Remy Derbass, who moderated the discussion. The event marked the launch of Organon’s services in Lebanon.
Participants highlighted the importance of addressing the gaps and discussing the challenges faced by Lebanese women, especially in these difficult circumstances that prevent their health needs from being met. They also emphasized on the importance of cooperation and partnership between all stakeholders to enable and support at all levels. The attendees agreed on the need to listen to women, to understand her needs mainly related to her health, the health of her family, achieving a successful work/life balance, and her mental well-being – All of which are in line with Organon’s goals of prioritizing women’s health.
Opening the event, Organon Levant Country Lead, Manal Dhainy, welcomed attendees and experts stating, “We thank you for being with us today, to listen to women’s voices and to discuss opportunities and solutions that ensure a healthier future for women and their families. Today, we are not only launching a women health company in Lebanon, but we are also declaring Organon commitment to every Lebanese woman and her family, especially during these hard times that Lebanon has been witnessing, and its health sector in particular”. She added, “We are keen to use our global footprint and the expertise that we have, by working closely with local authorities and stakeholders in the healthcare sector, to transform women’s lives and move beyond their reproductive needs and make them more inclusive”.
Director of Women Integrated Sexual Health (WISH) Program of the ObGyn Department at AUBMC and Chair of Arab Woman Health Group, Dr. Faysal El Kak stated, “Promoting women’s health and wellness is a fundamental goal of health professionals and communities and can’t be achieved unless by collective work and shared responsibility. Putting women at the center of care is essential to understand and provide not only their unmet needs but also to sustain and advance their total health and wellness through prevention, early screening and intervention through multidisciplinary approach and proper counseling on lifestyle modification and encouraging adoption of regular health care and healthy practices across lifespan”.
Gynecologist, Sexologist, Dr. Layal Abi Zeid, added, “Being a woman is a chance to live a new experience in every phase of life. The menopause period is one of them that is why the stigma should be eliminated and the menopause considered as a new Period of liberation. The health sector plays a major role here: offering the maximum service to make the sickness easier and have a holistic approach to the medical case not only the chief complaint of the patient.”
On the other hand, Dr. Colette Raidy, Head of the Pharmacy Department at the Ministry of Public Health, added, “Mothers and wives have a direct impact on the psychological and physical well-being of the family, they are the source from which the family draws its strength”. She continued, “Education, Partnership and Empowerment also play a prominent role in this regard and help achieve the desired successful results.”
President of ICF Lebanon Chapter, Executive and Leadership Coach, Mrs. Nadine Zeinoun explained how Creating Equilibrium in families requires a complete mindset shift in both men and women. The first ingredient to making this shift, is for women to regain their Self-Worth. Without self-worth, a woman can never empower herself nor empower others around her.
With a diverse portfolio spanning Women’s Health, Biosimilars and Established Brands, Organon is keen to shift the focus of women’s healthcare beyond female reproduction to unaddressed needs, serving 140 markets with 60 medicines and solutions.
Through constant listening and continuous collaboration with all stakeholders of the health sector, Organon’s aim is to always support communities in building a healthier tomorrow by providing women and their families with the support they need because they deserve to be cared for.
About Organon:
Organon (NYSE: OGN) is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives. Here for her health, the company has a portfolio of more than 60 medicines and products across a range of therapeutic areas. Led by the reproductive health portfolio coupled with an expanding biosimilars business and stable franchise of established medicines, Organon’s products produce strong cash flows that will support investments in future growth opportunities in women’s health, including business development. In addition, Organon is pursuing opportunities to collaborate with biopharmaceutical innovators looking to commercialize their products by leveraging its scale and presence in fast growing international markets.
Organon has a global footprint with significant scale and geographic reach, world-class commercial capabilities, and approximately 9,000 employees with headquarters located in Jersey City, New Jersey.
For more information, visit www.organon.com and connect with us on LinkedIn, Instagram and Facebook.